{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T14:39:35Z","timestamp":1751467175146,"version":"3.32.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.lfs.2006.06.020","type":"journal-article","created":{"date-parts":[[2006,6,21]],"date-time":"2006-06-21T13:32:12Z","timestamp":1150896732000},"page":"1929-1935","source":"Crossref","is-referenced-by-count":2,"title":["Phosphodiesterase 4 inhibitors modulate \u03b22-adrenoceptor agonist-induced human airway hyperresponsiveness"],"prefix":"10.1016","volume":"79","author":[{"given":"Christophe","family":"Faisy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul-Andr\u00e9","family":"Risse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Naline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Guerot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Yves","family":"Fagon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillipe","family":"Devillier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Advenier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2006.06.020_bib1","doi-asserted-by":"crossref","first-page":"7997","DOI":"10.1074\/jbc.M407521200","article-title":"Phosphodiesterase 4D forms a cAMP diffusion barrier at the apical membrane of the airway epithelium","volume":"280","author":"Barnes","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.lfs.2006.06.020_bib2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1152\/physrev.1995.75.4.725","article-title":"Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms","volume":"75","author":"Beavo","year":"1995","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.lfs.2006.06.020_bib3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0165-6147(90)90066-H","article-title":"Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors","volume":"11","author":"Beavo","year":"1990","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.lfs.2006.06.020_bib4","first-page":"L412","article-title":"Modulation of human airway smooth muscle proliferation by type 3 phosphodiesterase inhibition","volume":"276","author":"Billington","year":"1999","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.lfs.2006.06.020_bib5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0898-6568(94)90018-3","article-title":"Molecular biology of the cyclic AMP-specific cyclic nucleotide phosphodiesterases: a diverse family of regulatory enzymes","volume":"6","author":"Bolger","year":"1994","journal-title":"Cellular Signalling"},{"issue":"Suppl 1","key":"10.1016\/j.lfs.2006.06.020_bib6","doi-asserted-by":"crossref","first-page":"s252","DOI":"10.1038\/sj.bjp.0706495","article-title":"Phosphodiesterase inhibitors","volume":"147","author":"Boswell-Smith","year":"2006","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.lfs.2006.06.020_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0922-4106(95)90100-0","article-title":"Desensitization of beta-adrenergic responses in adipocytes involves receptor subtypes and cAMP phosphodiesterase","volume":"289","author":"Bousquet-Melou","year":"1995","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.lfs.2006.06.020_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1513\/pats.200411-054SF","article-title":"Future directions in the pharmacologic therapy of chronic obstructive pulmonary disease","volume":"2","author":"Buhl","year":"2005","journal-title":"Proceedings of the American Thoracic Society"},{"key":"10.1016\/j.lfs.2006.06.020_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1465-9921-5-4","article-title":"The effect of selective phosphodiesterase inhibitors, alone and in combination, on a murine model of allergic asthma","volume":"5","author":"Clayton","year":"2004","journal-title":"Respiratory Research"},{"key":"10.1016\/j.lfs.2006.06.020_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0140-6736(01)05481-2","article-title":"Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study","volume":"358","author":"Compton","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2006.06.020_bib11","doi-asserted-by":"crossref","first-page":"L1033","DOI":"10.1152\/ajplung.00063.2002","article-title":"In vitro sensitization of human bronchus by beta2-adrenergic agonists","volume":"283","author":"Faisy","year":"2002","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.lfs.2006.06.020_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00210-004-0974-x","article-title":"Nociceptin inhibits vanilloid TRPV-1-mediated neurosensitization induced by fenoterol in human isolated bronchi","volume":"370","author":"Faisy","year":"2004","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.lfs.2006.06.020_bib13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1165\/rcmb.2005-0091OC","article-title":"{beta}2-Adrenoceptor agonist modulates endothelin-1-receptors in human isolated bronchi","volume":"34","author":"Faisy","year":"2005","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.lfs.2006.06.020_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1172\/JCI8374","article-title":"Albuterol-induced downregulation of Gsalpha accounts for pulmonary beta(2)-adrenoceptor desensitization in vivo","volume":"106","author":"Finney","year":"2000","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.lfs.2006.06.020_bib15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1165\/ajrcmb.20.2.3140","article-title":"Identification and function of cyclic nucleotide phosphodiesterase isoenzymes in airway epithelial cells","volume":"20","author":"Fuhrmann","year":"1999","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.lfs.2006.06.020_bib16","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1164\/rccm.200212-1490OC","article-title":"Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease","volume":"168","author":"Gamble","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.lfs.2006.06.020_bib17","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1517\/13543784.10.7.1361","article-title":"Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease","volume":"10","author":"Giembycz","year":"2001","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.lfs.2006.06.020_bib18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.coph.2005.04.001","article-title":"Life after PDE4: overcoming adverse events with dual-specificity phosphodiesterase inhibitors","volume":"5","author":"Giembycz","year":"2005","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.lfs.2006.06.020_bib19","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1513\/pats.200504-041SR","article-title":"Phosphodiesterase-4: selective and dual-specificity inhibitors for the therapy of chronic obstructive pulmonary disease","volume":"2","author":"Giembycz","year":"2005","journal-title":"Proceedings of the American Thoracic Society"},{"key":"10.1016\/j.lfs.2006.06.020_bib20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1124\/jpet.300.2.559","article-title":"Immunopharmacological potential of selective phosphodiesterase inhibition. I. Differential regulation of lipopolysaccharide-mediated proinflammatory cytokine (interleukin-6 and tumor necrosis factor-alpha) biosynthesis in alveolar epithelial cells","volume":"300","author":"Haddad","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.lfs.2006.06.020_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0022-3565(24)29537-9","article-title":"Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro","volume":"297","author":"Hatzelmann","year":"2001","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.lfs.2006.06.020_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/scdb.1997.0221","article-title":"Adaptation in cyclic AMP signalling processes: a central role for cyclic AMP phosphodiesterases","volume":"9","author":"Houslay","year":"1998","journal-title":"Seminars in Cell and Developmental Biology"},{"key":"10.1016\/j.lfs.2006.06.020_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/pulp.1995.1010","article-title":"Inhibition of antigen-induced pulmonary eosinophilia and neutrophilia by selective inhibitors of phosphodiesterase types 3 or 4 in Brown Norway rats","volume":"8","author":"Howell","year":"1995","journal-title":"Pulmonary Pharmacology"},{"key":"10.1016\/j.lfs.2006.06.020_bib24","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1164\/rccm.2308001","article-title":"Phosphodiesterase 4 inhibitors: antiinflammatory therapy for chronic obstructive pulmonary disease at last?","volume":"168","author":"Kerstjens","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.lfs.2006.06.020_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/01926230490431493","article-title":"The toxicity of SCH 351591, a novel phosphodiesterase-4 inhibitor, in Cynomolgus monkeys","volume":"32","author":"Losco","year":"2004","journal-title":"Toxicologic Pathology"},{"key":"10.1016\/j.lfs.2006.06.020_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/abbi.1995.1429","article-title":"Diversity in cyclic nucleotide phosphodiesterase isoenzyme families","volume":"322","author":"Manganiello","year":"1995","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/j.lfs.2006.06.020_bib27","first-page":"810","article-title":"Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B","volume":"276","author":"Manning","year":"1996","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.lfs.2006.06.020_bib28","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1096\/fj.03-0274com","article-title":"PDE4D plays a critical role in the control of airway smooth muscle contraction","volume":"17","author":"Mehats","year":"2003","journal-title":"FASEB Journal"},{"key":"10.1016\/j.lfs.2006.06.020_bib29","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0165-6147(96)10035-3","article-title":"Subtypes of the type 4 cAMP phosphodiesterases: structure, regulation and selective inhibition","volume":"17","author":"Muller","year":"1996","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.lfs.2006.06.020_bib30","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s002100000215","article-title":"Beta-adrenoceptor stimulation up-regulates phosphodiesterase 4 activity and reduces prostaglandin E2-inhibitory effects in human neutrophils","volume":"361","author":"Ortiz","year":"2000","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.lfs.2006.06.020_bib31","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1472-8206.1996.tb00587.x","article-title":"Salbutamol potentiates the relaxant effects of selective phosphodiesterase inhibitors on guinea pig isolated trachea","volume":"10","author":"Planquois","year":"1996","journal-title":"Fundamental and Clinical Pharmacology"},{"key":"10.1016\/j.lfs.2006.06.020_bib32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/thorax.58.7.573","article-title":"Effect of cilomilast (Ariflo) on TNF-alpha, IL-8, and GM-CSF release by airway cells of patients with COPD","volume":"58","author":"Profita","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.lfs.2006.06.020_bib34","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1476-5381.1993.tb13641.x","article-title":"Effects of rolipram and siguazodan on the human isolated bronchus and their interaction with isoprenaline and sodium nitroprusside","volume":"109","author":"Qian","year":"1993","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.lfs.2006.06.020_bib33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1183\/09031936.94.07020306","article-title":"Rolipram, but not siguazodan or zaprinast, inhibits the excitatory noncholinergic neurotransmission in guinea-pig bronchi","volume":"7","author":"Qian","year":"1994","journal-title":"European Respiratory Journal"},{"key":"10.1016\/j.lfs.2006.06.020_bib35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(05)67100-0","article-title":"Roflumilast-an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial","volume":"366","author":"Rabe","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2006.06.020_bib36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pharmthera.2004.12.001","article-title":"PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression","volume":"106","author":"Sanz","year":"2005","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.lfs.2006.06.020_bib37","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/01926230390241972","article-title":"Apoptosis and nitrative stress associated with phosphodiesterase inhibitor-induced mesenteric vasculitis in rats","volume":"31","author":"Slim","year":"2003","journal-title":"Toxicologic Pathology"},{"key":"10.1016\/j.lfs.2006.06.020_bib38","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.bjp.0705517","article-title":"Impaired host defense to Klebsiella pneumoniae infection in mice treated with the PDE4 inhibitor rolipram","volume":"140","author":"Soares","year":"2003","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.lfs.2006.06.020_bib39","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0955-0674(99)00073-3","article-title":"Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions","volume":"12","author":"Soderling","year":"2000","journal-title":"Current Opinion in Cell Biology"},{"key":"10.1016\/j.lfs.2006.06.020_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1476-5381.1993.tb13439.x","article-title":"Comparison of the effects of selective inhibitors of phosphodiesterase types III and IV in airway smooth muscle with differing beta-adrenoceptor subtypes","volume":"108","author":"Tomkinson","year":"1993","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.lfs.2006.06.020_bib41","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1164\/ajrccm.157.2.9708012","article-title":"Phosphodiesterase isozymes: molecular targets for novel antiasthma agents","volume":"157","author":"Torphy","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.lfs.2006.06.020_bib43","first-page":"1195","article-title":"Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity","volume":"263","author":"Torphy","year":"1992","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.lfs.2006.06.020_bib42","first-page":"1213","article-title":"Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle","volume":"265","author":"Torphy","year":"1993","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.lfs.2006.06.020_bib44","doi-asserted-by":"crossref","first-page":"23598","DOI":"10.1074\/jbc.270.40.23598","article-title":"Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. Implications for the therapeutic use of beta-adrenoceptor agonists","volume":"270","author":"Torphy","year":"1995","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.lfs.2006.06.020_bib45","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/jpet.301.1.241","article-title":"Pharmacological profile of a novel phosphodiesterase 4 inhibitor, 4-(8-benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic acid (NVP-ABE171), a 1,7-naphthyridine derivative, with anti-inflammatory activities","volume":"301","author":"Trifilieff","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.lfs.2006.06.020_bib46","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1006\/bbrc.1997.6636","article-title":"Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) subtypes A, B, C, and D","volume":"234","author":"Wang","year":"1997","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.lfs.2006.06.020_bib47","first-page":"L694","article-title":"Phosphodiesterase expression in human epithelial cells","volume":"275","author":"Wright","year":"1998","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.lfs.2006.06.020_bib48","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1073\/pnas.0405263102","article-title":"Phosphodiesterase 4D is required for beta2 adrenoceptor subtype-specific signaling in cardiac myocytes","volume":"102","author":"Xiang","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320506004838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320506004838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:09:43Z","timestamp":1736431783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320506004838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":48,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0024320506004838"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2006.06.020","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}